Risk stratification models, such as the Fetal Medicine Foundation algorithm incorporating maternal characteristics, mean arterial pressure, uterine artery pulsatility index, and biochemical markers (PlGF, PAPP-A), achieve 90% detection rates for early-onset preeclampsia while maintaining 10% screen-positive rates [22]. The gene discussed is PAPPA; the disease is preeclampsia.